ID   IMA
AC   CVCL_E1HV
SY   TB096; TB096-2; TB09-0096-2; IDH1-Mutated Astrocytoma
DR   Millipore; SCC431
RX   PubMed=23204232;
CC   Doubling time: ~72 hours (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg781Ter (c.2341C>T); Zygosity=Unspecified (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23204232).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=23204232).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Millipore=SCC431
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,14
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 12,14
ST   FGA: 22,22.2
ST   Penta D: 14,15
ST   Penta E: 11,14
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=23204232; DOI=10.1158/0008-5472.CAN-12-2852; PMCID=PMC3548957;
RA   Jin G.-L., Reitman Z.J., Duncan C.G., Spasojevic I., Gooden D.M.,
RA   Rasheed B.K.A., Yang R., Lopez G.Y., He Y.-P., McLendon R.E.,
RA   Bigner D.D., Yan H.;
RT   "Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate
RT   production in IDH1-mutated gliomas.";
RL   Cancer Res. 73:496-501(2013).
//